4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-22-023695
VP, Research sold 5,000 shares at $25.59 ($127,950)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairman Jeff VP, Research | 2022-04-05 | Sale | −5,000 | $25.59 | $127,950 | 326,227 | I: show line 1 in the form |
| Open-market sales · 5,000 sh · avg $25.59 · $127,950 | |||||||
Loading xslF345X03/doc4.xml…